Back

GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

30 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Heart failure therapies: current drug strategies Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Caio Rodrigues Rosa

Belo Horizonte (Brazil)

6 More presentations in this session

Presentation thumbnail
Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure
Doctor L. Xie (Nanjing, CN)
Abstract Slides
Presentation thumbnail
Levosimendan in advanced heart failure: a step forward in functional recovery and hospitalization reduction
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Early exercise-based rehabilitation for patients with acute decompensated heart failure: an updated systematic review and meta-analysis
Mr D. Abraham (Manaus, BR)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitor therapy in patients with acute Takotsubo syndrome
Doctor L. Arcari (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Demographic, clinical and treatment patterns of patients with heart failure with reduced ejection fraction (HFrEF) in the Australian primary care setting
Associate Professor A. Nelson (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure therapies: current drug strategies

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of GLP-1 agonists on heart failure with preserved ejection fraction in obese patients: a meta-analysis of cardiometabolic and functional outcomes
thumbnail
Congress Presentation
Primary prevention of heart failure with glucagon-like peptide-1 receptor agonist
thumbnail
Congress Presentation
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources